Skip to main content
Fig. 2 | BMC Urology

Fig. 2

From: The efficacy of mirabegron additional therapy for lower urinary tract symptoms after treatment with α1-adrenergic receptor blocker monotherapy: prospective analysis of elderly men

Fig. 2

Changes in the measurements of objective symptoms in patients overall. The white columns show the values at 0 weeks, and the black columns show those at 12 weeks. After 12 weeks of α1-adrenergic receptor blocker and mirabegron combination therapy, the voided volume and maximum flow rate improved significantly. Post-void residual urine increased at the end of the period; however, this change was not statistically significant. SD, standard deviation

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us